| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |